“…There is growing interest in serum biomarker tests for ovarian cancer, melanoma, and prostate cancer including the potential role for exosome screening (Li et al, 2009; Logozzi et al, 2009; Lu et al, 2009; Poliakov et al, 2009; Smith et al, 1997; Tavoosidana et al, 2011; Taylor and Gercel-Taylor, 2008). A number of miRNAs, such as miR-34a, miR-130, miR-98, miR-124, miR-204, miR-142, miR-184 and miR-130a, have been shown to contribute to autophagy and phagocytosis (Alexandrov et al, 2013; Murad et al, 2014; Zhai et al, 2013). These are two cellular processes thought to play important roles in the pathogenesis of glaucoma, particularly at the level of the trabecular meshwork (Gasiorowski and Russell, 2009).…”